C4X Discovery Holdings PLC (C4XD)

London
17.35
-0.15(-0.86%)
  • Volume:
    36,402
  • Bid/Ask:
    16.85/27.00
  • Day's Range:
    17.25 - 18.00

C4XD Overview

Prev. Close
17.4
Day's Range
17.25-18
Revenue
2.71M
Open
18
52 wk Range
16.2-38.4
EPS
-0.036
Volume
36,402
Market Cap
44.12M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
580,174
P/E Ratio
-4.86
Beta
0.398
1-Year Change
-47.9%
Shares Outstanding
252,119,597
Next Earnings Date
26 Apr 2023
What is your sentiment on C4X Discovery Holdings PLC?
or
Market is currently closed. Voting is open during market hours.

C4X Discovery Holdings PLC News

C4X Discovery Holdings PLC Company Profile

C4X Discovery Holdings PLC Company Profile

C4X Discovery Holdings plc operates as drug discovery company in the United Kingdom. The company provides Taxonomy3, a novel in silico platform technology that utilizes proprietary mathematical algorithms to perform complex multivariate analysis of genetic data; Conformetrix, a technology platform which allows 3D-shapes of free drug molecules to be measured from experimental data, giving medicinal chemists new and unprecedented insights into the behavior and physical properties of drug molecules; and 4Sight for visualizing 4D molecules in virtual reality research scientists to view, understand and interrogate the complex, multidimensional molecular shape data of drug molecules. Its product pipeline includes Orexin-1, a receptor antagonist for the treatment of addictive disorders; NRF-2 activator to treat various inflammatory diseases; IL-17A inhibitor for inflammation and autoimmune diseases; a4ß7 integrin inhibitors for the treatment of inflammatory bowel disease; and MALT-1 inhibitors to treat hematological cancer. It has partnerships with Sanofi, therapeutics, horizon, LifeArc, INDIVIOR, and Phoremost. The company was formerly known as Schosween 24 plc and changed its name to C4X Discovery Holdings plc October 2014. The company was incorporated in 2007 and is based in Manchester, the United Kingdom.

Read More

Analyst Price Target

Average48.00 (+176.66% Upside)
High48.00
Low48.00
Price17.35
No. of Analysts1
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell